| Gilead Sciences Switzerland Sàrl - Epclusa, Filmtabletten | | 66095 | | 01 | | Epclusa | | Filmtabletten | | J05AP55 | | Sofosbuvir and Velpatasvir | | 22.09.2016 | | |
| | Composition | | sofosbuvirum 400 mg, velpatasvirum 100 mg, copovidonum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 2.85 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Sofosbuvirum | 400 mg | | Velpatasvirum | 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Sofosbuvirum | 400 mg | | Velpatasvirum | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copovidonum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 | 9825.75 | 10389.00 | A | LS | Oui |
|
|
